Fernando J. Irazoqui

673 total citations
36 papers, 557 citations indexed

About

Fernando J. Irazoqui is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Fernando J. Irazoqui has authored 36 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Immunology. Recurrent topics in Fernando J. Irazoqui's work include Glycosylation and Glycoproteins Research (21 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Peripheral Neuropathies and Disorders (10 papers). Fernando J. Irazoqui is often cited by papers focused on Glycosylation and Glycoproteins Research (21 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Peripheral Neuropathies and Disorders (10 papers). Fernando J. Irazoqui collaborates with scholars based in Argentina, Denmark and Japan. Fernando J. Irazoqui's co-authors include Gustavo A. Nores, Ricardo D. Lardone, Pablo H.H. López, M.E. Carrizo, Hugo L. Monaco, Massimiliano Perduca, Stefano Capaldi, Henrik Clausen, Eric Bennett and Victor G. Sendra and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Fernando J. Irazoqui

36 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando J. Irazoqui Argentina 14 363 201 130 107 92 36 557
Daniel Bartfeld Israel 12 566 1.6× 125 0.6× 88 0.7× 85 0.8× 84 0.9× 16 827
Norbert Madry Germany 12 240 0.7× 27 0.1× 36 0.3× 40 0.4× 34 0.4× 18 407
Lanmin Zhai United States 12 383 1.1× 57 0.3× 14 0.1× 49 0.5× 21 0.2× 16 652
Masayoshi Tsukahara Japan 12 480 1.3× 39 0.2× 51 0.4× 19 0.2× 11 0.1× 31 634
Hilary Lewis United Kingdom 10 515 1.4× 65 0.3× 36 0.3× 10 0.1× 63 0.7× 12 888
Eva Greiner Germany 12 627 1.7× 75 0.4× 10 0.1× 23 0.2× 22 0.2× 18 888
Kazuo Kamemura Japan 12 540 1.5× 202 1.0× 15 0.1× 183 1.7× 6 0.1× 32 628
Fitsum Tamene Finland 6 246 0.7× 20 0.1× 68 0.5× 23 0.2× 8 0.1× 6 461
Cheryl M. Ethen United States 10 376 1.0× 50 0.2× 66 0.5× 81 0.8× 5 0.1× 16 506

Countries citing papers authored by Fernando J. Irazoqui

Since Specialization
Citations

This map shows the geographic impact of Fernando J. Irazoqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando J. Irazoqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando J. Irazoqui more than expected).

Fields of papers citing papers by Fernando J. Irazoqui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando J. Irazoqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando J. Irazoqui. The network helps show where Fernando J. Irazoqui may publish in the future.

Co-authorship network of co-authors of Fernando J. Irazoqui

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando J. Irazoqui. A scholar is included among the top collaborators of Fernando J. Irazoqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando J. Irazoqui. Fernando J. Irazoqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lardone, Ricardo D., et al.. (2021). How glycobiology can help us treat and beat the COVID-19 pandemic. Journal of Biological Chemistry. 296. 100375–100375. 18 indexed citations
3.
Lardone, Ricardo D., Fernando J. Irazoqui, & Gustavo A. Nores. (2019). Most of anti-glycolipid IgG-antibodies associated to neurological disorders occur without their IgM counterpart. Journal of Biomedical Science. 26(1). 67–67. 4 indexed citations
4.
Lorenz, Virginia O., M.E. Carrizo, Eric Bennett, et al.. (2016). Extrinsic Functions of Lectin Domains in O-N-Acetylgalactosamine Glycan Biosynthesis. Journal of Biological Chemistry. 291(49). 25339–25350. 12 indexed citations
5.
Moyano, Ana Lis, et al.. (2012). Novel antibodies reacting with two neighboring gangliosides are induced in rabbits immunized with bovine brain gangliosides. Glycobiology. 22(12). 1768–1774. 1 indexed citations
6.
Sendra, Victor G., Virginia O. Lorenz, Marcos A. Villarreal, et al.. (2011). Catalytic and glycan-binding abilities of ppGalNAc-T2 are regulated by acetylation. Biochemical and Biophysical Research Communications. 410(1). 140–145. 7 indexed citations
7.
Lardone, Ricardo D., Nobuhiro Yuki, Masaaki Odaka, et al.. (2009). Anti-GM1 IgG antibodies in Guillain-Barre syndrome: fine specificity is associated with disease severity. Journal of Neurology Neurosurgery & Psychiatry. 81(6). 629–633. 22 indexed citations
8.
Sendra, Victor G., Eric Bennett, Henrik Clausen, et al.. (2009). Glycan bioengineering in immunogen design for tumor T antigen immunotargeting. Molecular Immunology. 46(16). 3445–3453. 4 indexed citations
10.
Nores, Gustavo A., et al.. (2007). Anti-GM1 antibodies as a model of the immune response to self-glycans. Biochimica et Biophysica Acta (BBA) - General Subjects. 1780(3). 538–545. 27 indexed citations
11.
Irazoqui, Fernando J., Ricardo D. Lardone, Marcos A. Villarreal, et al.. (2005). Fine carbohydrate recognition of Euphorbia milii lectin. Biochemical and Biophysical Research Communications. 336(1). 14–21. 14 indexed citations
12.
Carrizo, M.E., Stefano Capaldi, Massimiliano Perduca, et al.. (2005). The Antineoplastic Lectin of the Common Edible Mushroom (Agaricus bisporus) Has Two Binding Sites, Each Specific for a Different Configuration at a Single Epimeric Hydroxyl. Journal of Biological Chemistry. 280(11). 10614–10623. 84 indexed citations
13.
Carrizo, M.E., Fernando J. Irazoqui, Ricardo D. Lardone, et al.. (2004). Crystallization and preliminary X-ray study of the common edible mushroom (Agaricus bisporus) lectin. Acta Crystallographica Section D Biological Crystallography. 60(4). 718–720. 4 indexed citations
14.
López, Pablo H.H., Ricardo D. Lardone, Fernando J. Irazoqui, Mariana Maccioni, & Gustavo A. Nores. (2002). The Origin of Anti-GM1 Antibodies in Neuropathies: The “Binding Site Drift” Hypothesis. Neurochemical Research. 27(7-8). 687–695. 13 indexed citations
15.
Irazoqui, Fernando J., Pablo H.H. López, Ulla Mandel, & Gustavo A. Nores. (2002). Influence of terminal residue on adjacent disaccharide immunogenicity. Molecular Immunology. 38(11). 825–831. 7 indexed citations
16.
López, Pablo H.H., Ricardo D. Lardone, Fernando J. Irazoqui, et al.. (2001). Variable patterns of anti-GM1 IgM-antibody populations defined by affinity and fine specificity in patients with motor syndromes: evidence for their random origin. Journal of Neuroimmunology. 119(1). 131–136. 14 indexed citations
18.
López, Pablo H.H., Fernando J. Irazoqui, & Gustavo A. Nores. (2000). Normal human plasma contains antibodies that specifically block neuropathy-associated human anti-GM1 IgG-antibodies. Journal of Neuroimmunology. 105(2). 179–183. 15 indexed citations
19.
Irazoqui, Fernando J., et al.. (2000). Novel immunogenicity of Thomsen-Friedenreich disaccharide obtained by a molecular rotation on its carrier linkage. Glycobiology. 10(8). 781–787. 9 indexed citations
20.
Irazoqui, Fernando J., et al.. (1997). Agaricus bisporus lectin binds mainly O-glycans but also N-glycans of human IgA subclasses. Glycoconjugate Journal. 14(3). 313–319. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026